Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 10, 2025, titled ""Ichnos Glenmark Innovation (IGI) Announces Global Commercialization Strategy for ISB 2001 Following Licensing Deal with AbbVie"".